Search

Your search keyword '"Lorenza Pecciarini"' showing total 64 results

Search Constraints

Start Over You searched for: Author "Lorenza Pecciarini" Remove constraint Author: "Lorenza Pecciarini"
64 results on '"Lorenza Pecciarini"'

Search Results

1. Case report: EML4::NTRK3 gene fusion in a patient with metastatic lung adenocarcinoma successfully treated with entrectinib

2. Gene Fusion Detection in NSCLC Routine Clinical Practice: Targeted-NGS or FISH?

Catalog

Books, media, physical & digital resources

3. Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses

4. Next Generation Sequencing in Non-Small Cell Lung Cancer: Pitfalls and Opportunities

5. Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironment

6. CDC25A Protein Stability Represents a Previously Unrecognized Target of HER2 Signaling in Human Breast Cancer: Implication for a Potential Clinical Relevance in Trastuzumab Treatment

8. Establishment and Characterization of PCL12, a Novel CD5+ Chronic Lymphocytic Leukaemia Cell Line.

9. Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples

10. Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma

11. Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can!

12. Intratumoral cellular heterogeneity: Implications for drug resistance in patients with non-small cell lung cancer

13. Next Generation Sequencing in Non-Small Cell Lung Cancer: Pitfalls and Opportunities

14. Acute Lung injury evolution in Covid-19

15. Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non-Small-Cell Lung Cancer

16. Acute Lung injury evolution in Covid-19

17. A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the 'CARMEN' phase II trial

18. Evidence of a common cell origin in a case of pancreatic mixed intraductal papillary mucinous neoplasm–neuroendocrine tumor

19. Identification and monitoring of somatic mutations in circulating cell-free tumor DNA in lung cancer patients

20. MYD88 L265P MUTATION DETECTION IN THE AQUEOUS HUMOR OF PATIENTS WITH VITREORETINAL LYMPHOMA

21. Rapid targeted somatic mutation analysis of solid tumors in routine clinical diagnostics

22. Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3d surrogate microenvironment

23. Establishment, characterization and long-term culture of human endocrine pancreas-derived microvascular endothelial cells

24. General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL

25. Abstract 645: Targeted next generation sequencing in molecular diagnostics of solid tumors

26. Abstract 5580: Identification and monitoring of somatic mutations in circulating cell-free DNA by next-generation sequencing in patients with lung adenocarcinoma

27. Chlamydophila psittaciis viable and infectious in the conjunctiva and peripheral blood of patients with ocular adnexal lymphoma: Results of a single‐center prospective case–control study

28. Human malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells

29. Characterization of t(6;11)(p21;q12) in a renal-cell carcinoma of an adult patient

30. Correction: Establishment and Characterization of PCL12, a Novel CD5+ Chronic Lymphocytic Leukaemia Cell Line

31. Alterations of β-Catenin Pathway in Non-Melanoma Skin Tumors

32. Uterine inflammatory myofibroblastic tumor in a 10-year-old girl presenting as polypoid mass

33. Abstract 744: ctDNA use in molecular diagnostics

34. Abstract 3519: TGF-β pathway alteration in pancreatic neuroendocrine tumors: characterization of a novel SMAD3 translocation

35. Abstract 756: Molecular characterization of triploid and tetraploid urine FISH samples

36. Identifying the primary sites of metastatic carcinoma: the increasing role of immunohistochemistry

37. PAX8-PPAR γ 1 Fusion in Oncogene Human Thyroid Carcinoma

38. A 'twist box' code of p53 inactivation: twist box: p53 interaction promotes p53 degradation

39. HER2 Testing in Gastric Cancer

40. Urocortin in amniotic fluid and Down syndrome

41. Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methods

42. Constitutive overexpression of CDC25A in primary human mammary epithelial cells results in both defective DNA damage response and chromosomal breaks at fragile sites

43. Chlamydia-psittaci-eradicating antibiotic therapy in patients with advanced-stage ocular adnexal MALT lymphoma

44. A transcription-dependent micrococcal nuclease-resistant fragment of the urokinase-type plasminogen activator promoter interacts with the enhancer

45. A woman and her canary: a tale of chlamydiae and lymphomas

46. Alterations of beta-catenin pathway in non-melanoma skin tumors: loss of alpha-ABC nuclear reactivity correlates with the presence of beta-catenin gene mutation

47. High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis

48. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast

49. Urocortin in amniotic fluid and Down syndrome

50. Small thymus in very low birth weight infants born to mothers with subclinical chorioamnionitis